Learn more

SUNG HSING-WEN

Overview
  • Total Patents
    44
About

SUNG HSING-WEN has a total of 44 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, medical technology and micro-structure and nano-technology are LABTEC GMBH, GP MEDICAL INC and ALLEN CHRISTINE.

Patent filings in countries

World map showing SUNG HSING-WENs patent filings in countries
# Country Total Patents
#1 United States 44

Patent filings per year

Chart showing SUNG HSING-WENs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tu Hosheng 44
#2 Sung Hsing-Wen 44
#3 Sonaje Kiran 15
#4 Chuang Er-Yuan 9
#5 Nguyen Ho-Ngoc 9
#6 Chen Mei-Chin 7
#7 Liao Zi-Xian 6
#8 Liang Hsiang-Fa 4
#9 Nguyen Ha Giang Thi 4
#10 Su Fang Yi 4

Latest patents

Publication Filing date Title
US8535640B1 Pharmaceutical composition of nanoparticles
US8574544B1 Pharmaceutical composition of nanoparticles
US8663599B1 Pharmaceutical composition of nanoparticles
US8791069B1 Pharmaceutical composition of nanoparticles
US8318198B1 Pharmaceutical composition of nanoparticles
US8318200B1 Pharmaceutical composition of nanoparticles
US8236281B1 Pharmaceutical composition of nanoparticles
US8287905B1 Pharmaceutical composition of nanoparticles
US8226928B1 Pharmaceutical composition of nanoparticles
US8337811B1 Pharmaceutical composition of nanoparticles
US8202508B1 Pharmaceutical composition of nanoparticles for protein drug delivery
US8187570B1 Nanoparticles for protein drug delivery
US8202839B1 Pharmaceutical composition of nanoparticles
US8221795B1 Composition of imaging nanoparticles
US8192718B1 Pharmaceutical composition of nanoparticles
US8119102B1 Pharmaceutical composition of nanoparticles
US8257740B1 Pharmaceutical composition of nanoparticles
US8153153B1 Pharmaceutical composition of nanoparticles for protein drug delivery
US8084493B1 Pharmaceutical composition of peptide drug and enzyme-inhibition compounds
US8187571B1 Pharmaceutical composition of nanoparticles